W
Wise Therapeutics
Creates science-based interventions in mental health
About Wise Therapeutics
Wise Therapeutics, now known as Arcade Therapeutics, was founded in 2018 by Dr. Tracy Dennis-Tiwary and Raj Amin. The company is headquartered in New York, USA.
Dr. Dennis-Tiwary, a professor of psychology and neuroscience, and Amin, with his background in digital health and mobile technology, combined their expertise to address the growing mental health crisis. Their goal was to create accessible and engaging digital solutions for mental wellness, backed by scientific research.
Wise Therapeutics develops and commercializes digital therapeutics in the form of mobile games. These games are designed to reduce stress and anxiety and are based on clinically validated research. The company's business model revolves around creating a pipeline of these game-based therapies, which they plan to get cleared by the FDA. This would allow the games to be prescribed by healthcare professionals, making them a part of mainstream mental health treatment. The company serves individuals seeking mental health support and aims to partner with healthcare providers and institutions.
One of their key products is "Personal Zen," an app that uses a game-based approach to help users build resilience against stress and anxiety. The app is designed to be used for just a few minutes each day and has been the subject of several clinical studies to validate its effectiveness.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- New York City, United States
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 83.3/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Mental Health, Digital Therapeutics, Hard Tech
- Business model
- SaaS
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Oct 2020 | $530K | $2.1M | SeedLink SL · Teem Ventures · Reshma Saujani | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Wise Therapeutics is 210 monthly website visits, down 71.2% over the last three months. Wise Therapeutics's team grew 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
SeedLink SL
Teem Ventures
Reshma Saujani
Other known investors1 additional known investor
BAT VC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Wise Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Wise Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.